Schedule

Friday, October 22, 2021

- PDT
SESSION 1: PROSTATE IMAGING

7:20 am – 7:30 am
Welcome - Arvin K. George, MD

7:30 am – 7:50 am
Prostate MRI for the Urologist
Baris Turkbey, MD

7:50 am – 8:05 am
The Manogram: Role of MRI in Prostate Cancer Screening
Peter A. Pinto, MD

8:05 am – 8:20 am
Discussion

- PDT
SESSION 2: INTRODUCTION TO FOCAL THERAPY

8:20 am – 8:35 am
Rationale for Focal Therapy
Jim Wysock, MD

8:35 am – 8:50 am
Selecting Candidates for Focal Therapy
Laurence Klotz, MD

8:50 am – 9:00 am
PET Imaging for Selection of Focal Therapy Candidates
Michael Gorin, MD

9:00 am – 9:15 am
Discussion

9:15 am – 9:45 am
BREAK

9:45 am – 10:00 am
Focal Therapy vs. Active Surveillance for Low Volume GG2 Disease
Stacy Loeb, MD

10:00 am – 10:10 am
Prostate Cancer Biomarkers and Focal Therapy
Simpa Salami, MD

10:10 am – 10:25 am
Point Counterpoint:

10:10 am
Focal Therapy Can Be Done for MRI Invisible Disease:  Arvin George, MD

10:17 am
Focal Therapy Should Not Be Done for MRI Invisible Disease: Simpa Salami, MD

10:25 am – 10:45 am
Introduction of Disruptive Technologies: The Lessons from the Minimally Invasive Surgery
Inderbir Gill, MD

10:45 am – 11:00 am
Discussion

11:00 am – 11:30 am
KEYNOTE LECTURE: The Unlikely Candidates: Focal Therapy for Low and High-Risk Prostate Cancer Patients
Caroline Moore, MD

11:30 am – 11:45 am
Discussion

- PDT
- PDT
SESSION 3: PRINCIPLES OF FOCAL TREATMENT

12:45 pm – 12:55 pm
Modalities, Maps and Margins: Optimizing Oncologic Efficacy
Rafael Sanchez Salas, MD

12:55 pm – 1:05 pm
Patient Safety: Operative Techniques to Minimize Morbidity
Lance Mynderse, MD

1:05 pm – 1:15 pm
Discussion

1:15 pm – 2:15 pm
Balloon Debate: Optimal Management of Radio-Recurrent Unifocal Disease
Moderator: Abhinav Sidana, MD, MPH

-Active SurveillanceStacy Loeb, MD

-Androgen Deprivation Therapy Amir Lebatschi, MD

-CryoThomas Polascik, MD, FACS

-HIFUCaroline Moore, MD

 -RadiationAmar Kishan, MD

-Salvage Radical Prostatectomy Peter Pinto, MD

- PDT
CONCURRENT COURSE: IN-OFFICE TRANSPERINEAL INTERVENTIONS

3:00 pm – 3:30 pm
In-Office Transperineal Interventions
Arvin K. George, MD

3:30 pm – 4:30 pm
In-Office Transperineal Interventions: Live Interactive Breakout session*

- PDT
CONCURRENT COURSE: STATE-OF-THE-ART BPH MANAGEMENT

3:00 pm – 3:10 pm
Introduction – Workup/Guidelines
Amin Herati, MD

3:10 pm – 3:20 pm
RezumChristopher Dixon, MD

3:20 pm – 3:30 pm
Urolift - Amin Herati, MD

3:30 pm – 3:40 pm
EnucleationJohn Wei, MD

3:40 pm – 3:50 pm
ITind - TBD

3:50 pm – 4:00 pm
AquablationBrian Helfand, MD

4:00 pm – 4:10 pm
Summary - Amin Herati, MD

4:10 pm – 4:20 pm
Discussion

4:20 pm – 4:30 pm
BREAK

4:30 pm – 6:00 pm
Live Interactive Breakout*

- PDT
CONCURRENT COURSE: FUSION GUIDED ABLATION

4:30 pm – 6:00 pm
Fusion Guided Ablation: Live Interactive Breakout Session*

- PDT

Saturday, October 23, 2021

- PDT
CONCURRENT COURSE: IN-OFFICE TRANSPERINEAL INTERVENTIONS

7:00 am – 7:30 am
In-Office Transperineal Interventions
Arvin K. George, MD

7:30 am – 8:30 am
In-Office Transperineal Interventions: Live Interactive Breakout session*

- PDT
CONCURRENT COURSE: STATE-OF-THE-ART BPH MANAGEMENT

7:00 am – 7:10 am
Introduction – Workup/GuidelinesI
Amin Herati, MD

7:10 am – 7:20 am
RezumChristopher Dixon, MD

7:20 am – 7:30 am
Urolift - Amin Herati, MD

7:30 am – 7:40 am
EnucleationJohn Wei, MD

7:40 am – 7:50 am
ITind - TBD

7:50 am – 8:00 am
AquablationBrian Helfand, MD

8:00 am – 8:10 am
Summary - Amin Herati, MD

8:10 am – 8:20 am
Discussion

8:20 am – 8:30 am
BREAK

8:30 am – 10:00 am
Live Interactive Breakout*

- PDT
CONCURRENT COURSE: FUSION GUIDED ABLATION

8:30 am – 10:00 am
Fusion Guided Ablation: Live Interactive Breakout Session*

- PDT
- PDT
SESSION 4: SURVEILLANCE AND OUTCOME ASSESSMENT AFTER FOCAL THEAPY

10:30 am – 10:40 am
Role of PSA and Biomarkers in Assessing Focal Therapy Success
TBD        

10:40 am – 10:50 am
MRI Imaging After Focal Therapy: What and When?
Baris Turkbey, MD

10:50 am – 11:00 am
Protocol Biopsy for Surveillance After Focal Therapy
Kia Michel, MD

11:00 am – 11:15 am
Discussion

- PDT
SESSION 5: FOCAL THERAPY CHALLENGES AND CASE DISCUSSIONS

11:15 am – 11:30 am
Complications of Focal Therapy - Risk Factors, Timepoints, Management
Rafael Sanchez Salas, MD

11:30 am – 11:50 am
Mechanisms and Management of Recurrence
Sameer Taneja, MD

11:50 am – 12:00 pm
Discussion

12:00 pm – 1:00 pm
LUNCH (Industry Sponsored)

1:00 pm – 1:15 pm
Abstract Presentations
Andre Abreu, MD

1:15 pm – 2:00 pm
Case Discussions
Andre Abreu, MD, Jonathan Coleman, MD, Rafael Sanchez Salas, MD, Samir S. Taneja, MD

2:00 pm – 2:15 pm
Outcomes of Existing Focal Therapy Energy Modalities
Amir Lebastchi, MD

2:15 pm – 2:25 pm
Focal Therapy Society Update
Thomas Polascik, MD, FACS

2:25 pm – 2:40 pm
Discussion

- PDT
SESSION 6: STARTING A FOCAL THERAPY PROGRAM

2:40 pm – 2:55 pm
Block by Block: Building a Focal Therapy Program
Art Rastinehad, DO

2:55 pm – 3:05 pm
Billing and Reimbursement*
Karen Cornett, Hugo Embert

3:05 pm – 3:20 pm
Discussion

- PDT
SESSION 7: FUTURE OF FOCAL THERAPY

3:20 pm – 3:30 pm
Prostate Ablation and Antitumor Immune Response
Abhinav Sidana, MD, MPH

3:30 pm – 3:40 pm
New Modality #1*

3:40 pm – 3:50 pm
New Modality #2*

3:50 pm – 4:00 pm
New Modality #3*

4:00 pm – 4:05 pm
Conclusion